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Introduction: Chronic pelvic pain is a syndrome of chronic non-malignant pain of multifac-
torial pathophysiology. Perineal, anal and coccygeal pain can be a form of failed-back
surgery syndrome or complex regional pain syndrome. Apart from conservative treatment
interventional methods are useful in this condition as neurolytic blocks or non-destructive
neuromodulation procedures. Peripheral nerve, spinal cord stimulation or sacral stimula-
tion can be applied.
Aim: We describe a minimally invasive method of sacral roots stimulation with percutane-
ous electrodes implanted through the sacral hiatus in the treatment of chronic pelvic pain.
Materials and methods: We evaluated a series of nine female patients with pelvic pain treated
with sacral roots stimulation in regard of efﬁcacy and complications of this method.
Results: Short-term results in all patients were satisfactory with statistically signiﬁcant
improvement (median VAS = 9 before surgery) (median VAS = 2 after implantation,
p = 0.001), (median VAS = 3 after 6 months, p = 0.043). The long-term follow-up revealed less
satisfactory result (median VAS = 6 after 12 months). High incidence of complications was
noted: mainly infection in 3/9 patients.
Conclusion: Sacral roots stimulation is a non-destructive and minimally invasive neuromo-
dulation method in the treatment of chronic pelvic pain. It can be effective even in the long-
term observation but special care is advised to secure aseptic conditions in the implantation
and to prevent the infection which leads to removal of the stimulating system.
# 2015 Polish Neurological Society. Published by Elsevier Sp. z o.o. All rights reserved.
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Chronic pelvic pain (CPP) is a syndrome of chronic non-
malignant pain of multifactorial pathophysiology occurring in
both sexes. The etiology and pathogenesis of this condition is
poorly understood and can be associated with disturbances in
skeletal, genitourinary, gastrointestinal systems. It has severe* Corresponding author at: Department of Neurosurgery, The 10th Milita
Poland. Tel.: +48 600954415; fax: +48 523787094.
E-mail address: psokal@wp.pl (P. Sokal).
http://dx.doi.org/10.1016/j.pjnns.2015.07.003
0028-3843/# 2015 Polish Neurological Society. Published by Elsevier Seffects on quality of life. The type of pain in CPP is usually
complex: visceral pain originating from organs of minor pelvis,
somatic when it comes from bones, joints or muscles of this
region and neuropathic one when the injury of peripheral or
central nervous system occurs. Coccycodynia is the occur-
rence of pain in the coccyx region of unclear origin. In most
cases a traumatic etiology is present [2]. The management of
CPP is multidisciplinary and involves several specialists. CPPry Research Hospital, Powstancow Warszawy 5, 85-681 Bydgoszcz,
p. z o.o. All rights reserved.
Fig. 1 – A 56-year-old female patient with perianal, burning,
idiopathic pain lasting 6 years, NRS = 9 treated with
tramadol and gabapentin. Two quadripolar electrodes
implanted into the sacral canal. Result 90% reduction of
pain. Due to infection after 1 month – removal of the
system.
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 4 9 ( 2 0 1 5 ) 3 0 7 – 3 1 2308can be treated conservatively with pharmacotherapy using
antibiotics and non-steroid anti-inﬂammatory drugs (NSAIDs)
in inﬂammatory conditions, antiepileptic drugs as gabapen-
tine, antidepressants as amitriptyline or muscle relaxants in
neuromuscular disorders. In the acute phase the ﬁrst choice of
treatment are NSAIDs. The physiotherapy and psychotherapy
are important adjuvant interventions. When conservative
treatment is insufﬁcient more aggressive methods can be
applied. Neurolytic blocks with local anesthetics and steroids
or radiofrequency lesions can be recommended [3,4]. Particu-
larly neurolytic blocks of the ganglion of Walther are
efﬁcacious with long-term relief and the low rate of complica-
tions [5]. In coccycodynia coccygectomy is not recommended
because of long-term moderate effects and increased risk of
major complications [2]. The CPP with predominance of
neuropathic pain can be the part of failed-back-surgery
syndrome (FBSS) or complex regional pain syndrome (CRPS)
which are indications for neuromodulation [3]. CPP is
supposed to be a form of CRPS and can ﬁll criteria of this
syndrome [6,7]. Neuromodulation procedures are not destruc-
tive but reversible. Spinal cord stimulation (SCS) is the most
popular and widespread type from neuromodulation techni-
ques. The reports of the effects of spinal cord or spinal conus
stimulation in CPP are not conclusive. The optimal localization
of electrode in SCS is not deﬁned and is to be considered and
discussed. An interesting and minimally invasive method of
treatment of CPP is peripheral nerve stimulation (PNS):
pudendal, illo-inquinal, genito-femoral or tibial nerve stimu-
lation [8]. Another option is a targeted stimulation (TS) in the
ﬁeld of the highest intensity of pain [4]. A sacral neuromodula-
tion (SN) is an electrical stimulation of sacral nerves which has
to modulate the function of neural reﬂexes and pain afferent
tracts. SN is an established therapy for lower urinary
dysfunction approved by FDA for urgency-frequency and
urinary incontinence. SN has been shown to have beneﬁts in
painful bladder syndrome/interstitial cystitis, urinary urge
incontinence, urinary nonobstructive retention, urinary ur-
gency as well as frequency and stool incontinence [9–11]. The
success rate after permanent implantation ranges from 66% to
77% in patients responding to test stimulation [12]. SN is
supposed to show better beneﬁts than standard medical
therapy [13]. The reduction of pain syndromes is observed in
both SN and PNS with better result in SN [14,15]. In SN
transforaminal implantation unilateral or bilateral is applied.
Sacral roots stimulation (SRS) is a neurostimulation of sacral
roots S2, S3, S4. SRS can be performed with anterograde,
retrograde percutaneously implanted electrodes.
The mechanism of the action of SN or SRS is based on
Melzack and Wall' gate theory [16]. It has to block afferent pain
transmission, activate descending inhibitory pathways, effect
on sympathetic system, modulate neuromediator activity in
dorsal horns.
2. Aim
We describe a minimally invasive, neuromodulative method
of the stimulation of the sacral roots with percutaneous
electrodes implanted through sacral hiatus in the treatment of
CPP based on our experience.3. Materials and methods
We evaluated the effects of SRS in the treatment of CPP in nine
female patients hospitalized in the Department of Neurosur-
gery of Military Research Hospital in Bydgoszcz Poland in years
2008–2013. Median age was 57 years, ranging from 41 to 77
years. Median duration of pain was 6 (range from 5 to 17).
Follow-up was from 1 to 48 months.
All patients gave the informed consent on surgical
treatment deﬁning risks, potential beneﬁts and on evaluation
of the effects of procedures, which were performed by personal
interview or clinical examination.
We assessed the intensity of pain before the treatment,
after the surgery, after 6 months and after 1 year in visual
analog scale (VAS). Depending on localization, etiology and
causative factor CPP in nine patients was divided on FBSS
(Nr = 4) and idiopathic CRPS (Nr = 5). Cases 1, 2 were treated
with SCS at the beginning with electrode localized epidurally
on the level of spinal conus, e.g.: Th12-L1. Surgery was
performed under general anesthesia and electrodes were
implanted through ﬂavectomy or partial laminectomy on
appropriate level under ﬂuoroscopic control. Due to poor
results of SCS we performed SRS in these patients. All nine
patients underwent the implantation of sacral percutaneous
electrodes (two or one; quadripolar or octopolar) through the
Fig. 2 – (a and b) Two octopolar electrodes. A 55-year-old female with perianal and coccygeal pain exacerbating during stool
excretion and menstrual bleeding or sitting radiating to buttock bilaterally for 14 years after traumatic coccygeal injury. She
was taking tramadol 600 mg/day, oxycodin 2T/day and gabapentin 600 mg/day. Reduction of pain 50%.
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 4 9 ( 2 0 1 5 ) 3 0 7 – 3 1 2 309sacral hiatus in seven cases operated in general anesthesia
and in two cases in local anesthesia.
4. Operative technique
The surgery can be performed either in general or local
anesthesia. A patient is in prone position. The implantation of
the electrode(s) through the sacral hiatus and insertion it into
the vertebral canal in order to cross the S4, S3, S2 sacral roots is
possible in local anesthesia under ﬂuoroscopic control. After
the introduction of percutaneous, cylindrical usually octopolar
or quadripolar leads into the sacral canal external stimulation
can be performed to estimate the coverage and the efﬁcacy of
trial stimulation (Figs. 1 and 2a,b). Later on advancement of
connecting lead and placement of implantable pulse generator
in the subcutaneous pocket in lumbar or buttock area can be
conducted preferably in general anesthesia.
5. Results
All nine patients were females suffering on CPP: perineal, anal,
perirectal, pudendal or coccygeal region pain. The origin of pain
in four cases (44%) lies in the remote effects of lumbar surgery
due to discopathy known as failed-back surgery syndrome
(FBSS), in other four cases (56%) we have idiopathic CPP or
posttraumatic, with sensory or thermal disturbances in the area
of pain ﬁlling the criteria of diagnosis of CRPS [7] (Table 1). All
patients had a statistically signiﬁcant improvement after thesurgery (median VAS = 9 before surgery) (median VAS = 2 after
implantation, p = 0.001), a good result was also observed after 6
months of observation (median VAS = 3, p = 0.043). The long-
term follow-up revealed a less satisfactory result and exacerba-
tion of pain in majority of patients (median VAS = 6 after 12
months) (Fig. 3). All patients noticed the improvement of life
comfort and felt discomfort after switching off the implanted
stimulator. Almost all patients (8/9) reduced analgesic medica-
tion. The patient with fecal incontinence reported the reduction
of these symptoms. The high incidence of complications was
noted: mainly infection – present in three patients and
migration of electrodes in two others (Fig. 4).
6. Discussion
In this paper we report a non-lesioning and neuromodulating
method of stimulation of sacral roots in order to treat CPP. This
is a minimally invasive technique of the percutaneous
implantation of electrodes into the sacral canal through the
sacral hiatus. Stimulation is reversible and always can be
turned off.
In our series we included female patients suffering of CPP of
a different origin. The patients' complaints were refractory to
conservative management. These patients are difﬁcult to
manage due to multiple causes and multiple pathways for
pain transmission from the pelvis. The greatest number of
cases were patients with perineal, anal and coccygeal pain.
Predominant painful dermatomes were S4, S5 in some cases
also S3, S2 and S1. The main target of neuromodulation was to
Table 1 – Characteristics of patients.
Nr Initials Age duration
of pain
in years
VAS before
surgery
Sort of pain electrodes VAS
after SCS
VAS
after SRS
VAS after
6 months
VAS
after 12
months
Medication Follow-up
1 BB 43 5 6 Perineal FBSS 2  4 5 2 3 – Reduction of tramadol After 6 months infection
removal
2 HJ 62 6 8 Perineal and coccygeal
FBSS
1  4 8 2 3 7 Tramadol not reduced 4 years – no medication
3 US 64 17 9 Perineal FBSS 2  4 – 4 4 4 Reduction of tramadol 1 year – electrode
migration
4 EP 57 6 9 CRPS idiopathic perineal 2  4 – 1 – – Reduction of gabapentin,
withdrawal of tramadol
After 1 m infection
removal
5 HP 77 12 9 CRPS idiopathic
vulvodynia
1  8 – 1 2 6 Carbamazepinum
withdrawal and tramadol
reduction
18 months migration
6 EM 55 14 9 Perineal and coccygeal
CRPS
2  8 – 3 3 – Withdrawal of oxycodon
and gabapentin, reduction
of tramadol
8 months migration and
infection-removal
7 IM 41 5 9 Coccycodynia and left leg 1  8 – 1 3 3 Codeine/paracetamol
withdrawal
12 months
8 EK 61 5 8 Perineal and perirectal
pain CRPS
2  8 – 2 3 4 Withdrawal of gabapentin
and reduction of
oxycodon
12 months
9 MU 48 9 8 Perineal FBSS and fecal
incontinence
2  8 – 1 1 3 Reduction of tramadol 12 months
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Fig. 3 – Statistically significant improvement after surgery
and after 6 months assessed in VAS score.
Fig. 4 – One octopolar electrode migrated from the sacral
canal. Due to local, purulent infection two electrodes and
IPG were removed after 9 months.
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intensity of pain at least 50% [17]. At the beginning we tried to
use spinal conus stimulation for proper coverage of pain area.
Due to insufﬁcient pain relief we had to replace electrodes into
the sacral canal to stimulate lower sacral roots in two cases
with successful long-term result. The improvement was
noticeable. Hunter et al. [3] demonstrated case series of
patients with CPP treated successfully with SCS and lead
placement at the T6–T7 regions reaching adequate coverage.
In our series we do not have patients with CPP treated with T6–
T7 SCS but we have two cases with spinal conus stimulation on
the level T12-L2. Hunter had one patient with spinal cord
stimulation who received good result although he noticed that
capture with stimulation of this region is difﬁcult to achieve
due to high mobility of the conus under dural sac [3]. In ouropinion, nowadays it is easier to stimulate sacral ﬁbers in
dorsal columns of spinal cord having availability of, for
instance, a ﬁve-column electrodes which are dedicated to
SCS. Alo and McKay used two sacral nerve root electrodes to
stimulate S2–S3 roots bilaterally with excellent result in pelvic
pain in interstitial cystitis [18]. Hope presented a case of
successful treatment of pelvic pain with SN with electrode
implanted at S3 level [1]. All patients after qualiﬁcation had
one stage surgery with permanently implanted IPG (implant-
able pulse generator) although we usually ask patients
whether they prefer trial stimulation. In two cases we
performed the implantation in local anesthesia and external
trial stimulation was conducted to ﬁnd the most optimal
localization of electrodes leads. One case was complicated
with infection 1 month after surgery which ended with
removal of pulse generator device and electrodes, although
the patient had signiﬁcant improvement for a month. The
patients report excellent relief of their CPP during ﬁrst months
after the implantation ranging from over 50% to 90%
diminished intensity of pain. Longer-term results are not so
satisfying and after 1 year we should by happy if the patient
reaches 50% improvement. The late failure of neuromodula-
tion is the result of development of true tolerance and not
always accurate assessment by patients degree of pain relief
[17]. Since we did not have trial stimulations we did not
excluded any patients from permanent implants and that is
why this group better reﬂects the efﬁcacy of this method in the
treatment of CPP. We have to admit that we have high
complication rate associated with infection despite the fact
that we meticulously follow the rules of antiseptic and aseptic
conditions of surgery. Bendersky i Yampolski reviewed
complications in SCS and presented recommendations allow-
ing on the reduction of the infection rate. Among them there
were antimicrobial prophylaxis before surgery, at least double
change of gloves, aseptic conditions, limited use of electro-
cautery, rinsing of wounds with aqueous povidone–iodine
solution, nonstriangulating sutures and avoidance of placing
devices or cables under incision line [19]. The last condition in
this method is difﬁcult to fulﬁll. Three cases of electrode
migration shows that this technique has its shortcomings
associated with difﬁculty of ﬁxing the electrode near the
coccygeal bone under the skin devoid of muscles and fascia
which could enable strong ﬁxation. Cases of infection were
treated at the beginning conservatively, after failed antibiotic
therapy devices had to be removed. Feler et al. [20] presented
opinion that retrograde (directed caudally) implantation of
electrodes offers superior effectiveness with fewer complica-
tions comparing to other methods of sacral neuromodulation.
The objective of proper neurostimulation is to achieve correct
coverage of the pain area with stimulation paresthesias and in
this way substantial and durable pain relief. Perineal, anal,
rectal and tailbone area can be covered by SRS. Parameters
modiﬁcation changes sensation of induced paresthesia. It
increases efﬁcacy of stimulation and contributes to further
improvement of comfort of life and pain relief. Eventual
interruption of stimulation helps the patients realize and
appreciate the value of this treatment [21]. It seems that SRS
should not be considered a panaceum for CPP but can be a part
of treatment ladder [22]. Unfortunately the procedure is
burdened with the increased risk of complications basing on
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 4 9 ( 2 0 1 5 ) 3 0 7 – 3 1 2312our experience and it must be kept in mind when treating
patients with CPP with this method.
The main limitation of this paper lies in a small number of
observed cases and lack of a control group and no other
outcome measures apart from visual analog scale. There are
trials, which were conducted in fecal and urinary incontinence
or interstitial cystitis but there are no many reports on series of
patients with perianal and coccygeal pain of another origin
treated with neuromodulation.
7. Conclusions
SRS could be a promising technique in patients with CPP. The
short-term therapeutic effects of this intervention are satis-
factory. It is non-destructive and minimally invasive method.
It can be effective even in the long-term observation but
particular care is advised to secure aseptic conditions in the
implantation and prevent the infection which leads to
eventual removal of the system.
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